Brief: Adaptimmune Therapeutics PLC Files For Mixed Shelf Of Up To $400 Million – SEC Filing
08/04/2022 21:42
April 8 (Reuters) - Adaptimmune Therapeutics PLC ADAP.O :
* ADAPTIMMUNE THERAPEUTICS PLC FILES FOR MIXED SHELF OF UP
TO $400
MILLION – SEC FILING
* ADAPTIMMUNE- SALES AGREEMENT PROSPECTUS SUPPLEMENT
COVERING
OFFERING OF UP TO $200 MILLION OF ADSS THAT MAY BE ISSUED UNDER
SALES AGREEMENT
Further company coverage: ADAP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptimmune Therapeutics
See all newsAdaptimmune Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 10 cents a share - Earnings Preview
Enters Settlement Agreement With MD Anderson - SEC Filing
Adaptimmune Therapeutics PLC reports results for the quarter ended March 31 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 12 cents a share - Earnings Preview